Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 14/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.62 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7503544 | 0.88 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL9024375 | 0.86 | PTGS2 (0.65) | PTGS2PTGS1PTGDR2 | |
| SCHEMBL8558824 | 0.84 | PTGS2 (0.45) | PTGS2PTGS1PTGDR2MAOAMAOB | |
| SCHEMBL7508511 | 0.83 | PTGS2 (0.54) | PTGS2PTGS1MAOAMAOBCA1 | |
| SCHEMBL7499215 | 0.83 | PTGS2 (0.54) | PTGS2PTGS1MAOAMAOBCA1 | |
| SCHEMBL7506192 | 0.81 | PTGS2 (0.67) | PTGS2PTGS1MAOAMAOBCA1 | |
| SCHEMBL7505884 | 0.81 | PTGS2 (0.67) | PTGS2PTGS1MAOAMAOBCA1 | |
| SCHEMBL7504997 | 0.81 | PTGS2 (0.63) | PTGS2PTGS1PTGDR2MAOAMAOB | |
| SCHEMBL7501957 | 0.81 | PTGS2 (0.54) | PTGS2PTGS1PTGDR2MAOAMAOB | |
| SCHEMBL8549078 | 0.79 | PTGS2 (0.40) | PTGS2PTGS1PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0699192-B1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-07-24 | — | — | EP | claimed |
| EP-0699192-A1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-03-06 | — | — | EP | claimed |
| WO-1994027980-A1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0699192-B1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-07-24 | — | — | EP | disclosed |
| EP-0699192-A1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027980-A1 | SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1994-12-08 | — | — | WO | disclosed |